Nome |
# |
PARP inhibition: a promising therapeutic target in ovarian cancer, file e3835316-f8c5-15e8-e053-a505fe0a3de9
|
192
|
Treatment of the Mayer-Rokitansky-Küster-Hauser syndrome with autologous in vitro cultured vaginal tissue. descriptive study of long-term results and patient outcomes, file e383531b-d677-15e8-e053-a505fe0a3de9
|
173
|
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis, file e383531c-4117-15e8-e053-a505fe0a3de9
|
128
|
Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review, file e3835316-17a5-15e8-e053-a505fe0a3de9
|
114
|
Postpartum Posterior Reversible Encephalopathy Syndrome (PRES): Three Case Reports and Literature Review, file e3835321-d87e-15e8-e053-a505fe0a3de9
|
111
|
Fertility preservation in gynaecologic cancers, file e383531a-7a28-15e8-e053-a505fe0a3de9
|
110
|
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials, file e383531b-f192-15e8-e053-a505fe0a3de9
|
110
|
Radiation therapy and serum salivary amylase in head and neck cancer, file e383531c-2e22-15e8-e053-a505fe0a3de9
|
105
|
Functions and the emerging role of the foetal liver into regenerative medicine, file e3835323-a1d9-15e8-e053-a505fe0a3de9
|
104
|
Defective DNA repair mechanisms in prostate cancer: impact of olaparib, file e3835318-6c94-15e8-e053-a505fe0a3de9
|
100
|
Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women, file e3835321-8251-15e8-e053-a505fe0a3de9
|
100
|
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients, file e383531e-9aa2-15e8-e053-a505fe0a3de9
|
77
|
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer, file e3835321-945a-15e8-e053-a505fe0a3de9
|
77
|
Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: a case report, file e3835325-2486-15e8-e053-a505fe0a3de9
|
63
|
Recurrent mantle cell lymphoma in the uterine cervix: a case report, file e3835327-bd1c-15e8-e053-a505fe0a3de9
|
54
|
Role of circulating biomarkers in platinum-resistant ovarian cancer, file e383532d-e17d-15e8-e053-a505fe0a3de9
|
47
|
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis, file e383532d-29ec-15e8-e053-a505fe0a3de9
|
41
|
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis, file e3835315-eaf0-15e8-e053-a505fe0a3de9
|
10
|
Dualistic classification of epithelial ovarian cancer: Surgical and survival outcomes in a large retrospective series, file e3835319-b005-15e8-e053-a505fe0a3de9
|
8
|
Iodized Salt May Not Be Sufficient to Guarantee an Adequate Iodine Intake in Pregnant Women, file f916ac5b-bdd7-4af6-86f0-9a94c7d215a6
|
8
|
Umbilical port site enterocutaneous fistula after laparoscopy for endometrial malignancy, file e3835311-d344-15e8-e053-a505fe0a3de9
|
7
|
Bevacizumab in ovarian cancer: state of the art and unanswered questions, file e3835316-3173-15e8-e053-a505fe0a3de9
|
7
|
The efficacy of preoperative low-residue diet on postoperative ileus following cesarean section, file fe5d9494-2fd5-4c13-9263-0f7d3a9bae1e
|
7
|
Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis, file e3835315-f2c8-15e8-e053-a505fe0a3de9
|
6
|
null, file e3835316-04cb-15e8-e053-a505fe0a3de9
|
6
|
Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques, file e3835318-4d69-15e8-e053-a505fe0a3de9
|
6
|
Paget's disease of the male breast: case report and a point of view from actual literature, file e383531b-e139-15e8-e053-a505fe0a3de9
|
6
|
Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy, file e3835315-a3c5-15e8-e053-a505fe0a3de9
|
5
|
null, file e3835315-e6f4-15e8-e053-a505fe0a3de9
|
5
|
null, file e3835317-067e-15e8-e053-a505fe0a3de9
|
5
|
P66. Pilot Study on Subserosal and Intramural Uterine Leiomyomas and Magnetic Resonance-guided Focused Ultrasound Surgery ( MRgFUS): Are there New Predictive Indexes?, file e3835317-07cc-15e8-e053-a505fe0a3de9
|
5
|
Recurrent ovarian cancer: the role of radiation therapy, file e3835318-713a-15e8-e053-a505fe0a3de9
|
5
|
Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer, file e383531a-d20d-15e8-e053-a505fe0a3de9
|
5
|
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer, file e3835328-7db6-15e8-e053-a505fe0a3de9
|
5
|
Isolated contralateral groin relapse in vulvar cancer., file e3835312-2226-15e8-e053-a505fe0a3de9
|
4
|
null, file e3835312-dfc0-15e8-e053-a505fe0a3de9
|
4
|
Chyle leak following neck dissection: could radiotherapy be considered a management option?, file e3835314-8bac-15e8-e053-a505fe0a3de9
|
4
|
Risk-reducing salpingo-oophorectomy: A meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers, file e3835315-cdc7-15e8-e053-a505fe0a3de9
|
4
|
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case report, file e3835319-a825-15e8-e053-a505fe0a3de9
|
4
|
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis, file e3835323-38f0-15e8-e053-a505fe0a3de9
|
4
|
Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study, file 5683724a-de7a-4c01-bd7c-78183e700a09
|
3
|
null, file e3835315-be68-15e8-e053-a505fe0a3de9
|
3
|
null, file e3835315-e9a9-15e8-e053-a505fe0a3de9
|
3
|
Vulvar malignancy in neurofibromatosis syndrome, file e3835319-d429-15e8-e053-a505fe0a3de9
|
3
|
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study, file e383531a-0a4a-15e8-e053-a505fe0a3de9
|
3
|
null, file e383531c-0824-15e8-e053-a505fe0a3de9
|
3
|
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis, file e3835323-18c1-15e8-e053-a505fe0a3de9
|
3
|
The use of misoprostol and mifepristone in second trimester interruption of pregnancy. State of art, file e3835326-c712-15e8-e053-a505fe0a3de9
|
3
|
Loop Electrosurgical Excision Procedure and Cold Knife Conization. which is the best? A large retrospective study, file 75abdfe3-b65b-418e-add5-80b301eb67f8
|
2
|
First case of isolated vaginal metastasis from breast cancer treated by surgery, file e3835312-1647-15e8-e053-a505fe0a3de9
|
2
|
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis, file e3835316-10d2-15e8-e053-a505fe0a3de9
|
2
|
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer., file e3835316-2700-15e8-e053-a505fe0a3de9
|
2
|
Update on fertility-sparing treatment in primary and recurrent endometrial cancer, file e3835318-008a-15e8-e053-a505fe0a3de9
|
2
|
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients, file e383531b-f120-15e8-e053-a505fe0a3de9
|
2
|
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials, file e3835322-0d45-15e8-e053-a505fe0a3de9
|
2
|
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study, file e3835323-8159-15e8-e053-a505fe0a3de9
|
2
|
null, file e3835312-55dc-15e8-e053-a505fe0a3de9
|
1
|
Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma. Younger and older patients should be equally treated. A prospective study and literature review, file e3835315-9769-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835316-02a9-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835316-11cb-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835316-11cd-15e8-e053-a505fe0a3de9
|
1
|
Endometrioma-associated infertility: is surgery still the best way to go?, file e3835316-2761-15e8-e053-a505fe0a3de9
|
1
|
Tecniche chirurgiche in ginecologia oncologica., file e3835316-2983-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835318-0c99-15e8-e053-a505fe0a3de9
|
1
|
Metronomic chemotherapy in head and neck cancer, file e383531c-13d2-15e8-e053-a505fe0a3de9
|
1
|
The EOLO (End-of-Life Ovarian Cancer) Study: Approach to ovarian cancer patients at the end of life, file e3835322-da20-15e8-e053-a505fe0a3de9
|
1
|
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature, file e3835323-7792-15e8-e053-a505fe0a3de9
|
1
|
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review, file e3835325-2a78-15e8-e053-a505fe0a3de9
|
1
|
Treatment of the Mayer-Rokitansky-Küster-Hauser syndrome with autologous in vitro cultured vaginal tissue. descriptive study of long-term results and patient outcomes, file e3835326-ead2-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835328-b604-15e8-e053-a505fe0a3de9
|
1
|
Totale |
1.890 |